For prostate cancer, Li et al. [88] indicated that LINC00261 promoted DKK3 transcription expression by recruiting GATA6, and DKK3 could induce cellular quiescence and inhibit tumor progression through activating the p38 MAPK signaling pathway. This evidence concerns the gene DKK3 and prostate cancer.